NCT00596180

Brief Summary

That SPECT brain imaging tracks and is consistent with clinical history and physical exam as well as cognitive testing.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2007

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2007

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

January 4, 2008

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 16, 2008

Completed
10.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

April 18, 2017

Status Verified

April 1, 2017

Enrollment Period

11.9 years

First QC Date

January 4, 2008

Last Update Submit

April 16, 2017

Conditions

Keywords

carbon monoxide poisoningbrain injury

Outcome Measures

Primary Outcomes (1)

  • SPECT brain imaging

    after completion of HBOT

Secondary Outcomes (2)

  • clinical history and physical exam

    after completion of HBOT

  • Neuropsychological testing

    After the final HBOT

Study Arms (1)

1

HBOT

Drug: HBOT

Interventions

HBOTDRUG

total body exposure to greater than atmospheric pressure oxygen

1

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults and children with non-acute carbon monoxide poisoning who underwent SPECT brain imaging as part of their evaluation and treatment. Retrospective chart review

You may qualify if:

  • Adults and children with non-acute carbon monoxide poisoning who underwent SPECT brain imaging as part of their evaluation and treatment

You may not qualify if:

  • None.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Family Physicians Center

Marrero, Louisiana, 70072, United States

RECRUITING

MeSH Terms

Conditions

Carbon Monoxide PoisoningBrain Injuries

Condition Hierarchy (Ancestors)

Gas PoisoningPoisoningChemically-Induced DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Paul G Harch, M.D.

    LSU School of Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Paul G Harch, M.D.

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Clinical Professor of Medicine

Study Record Dates

First Submitted

January 4, 2008

First Posted

January 16, 2008

Study Start

January 1, 2007

Primary Completion

December 1, 2018

Study Completion

December 1, 2019

Last Updated

April 18, 2017

Record last verified: 2017-04

Data Sharing

IPD Sharing
Will not share

Locations